Kim Jinhyun, Lee Tae Jin, Kim Sungjae, Lee Eunhee
a a College of Nursing/The Research Institute of Nursing Science, Seoul National University , Seoul , the Republic of Korea.
b b School of Public Health, Seoul National University , Seoul , the Republic of Korea.
J Med Econ. 2016;19(2):103-10. doi: 10.3111/13696998.2015.1100114. Epub 2015 Oct 19.
This study examines the epidemiology and economic impact of chronic obstructive pulmonary disease (COPD) at a nationwide level in South Korea.
This retrospective analysis used the societal cost-of-illness framework, consisting of direct medical costs, direct non-medical costs, and indirect costs. In order to analyze the societal costs of patients with COPD, this study used a data mining and a macro-costing method on data from a South Korean national-level health survey and a national health insurance claims database from 2004-2013.
The total societal cost of COPD in 2013 was estimated to be $439.9 million for 1,419,914 patients. The direct medical cost for COPD was $214.3 million, which included a hospitalization cost of $96.3 million, an outpatient cost of $76.4 million, and a pharmaceutical cost of $41.6 million. The direct non-medical cost was estimated at $43.5 million. The indirect overall cost associated with the morbidity and mortality of COPD was $182.2 million in 2013.
This study showed that COPD has a major effect on healthcare costs, particularly direct medical costs. Thus, appropriate long-term interventions are recommended to lower the economic burden of COPD in South Korea.
本研究在韩国全国范围内考察慢性阻塞性肺疾病（COPD）的流行病学及经济影响。
本回顾性分析采用疾病社会成本框架，包括直接医疗成本、直接非医疗成本和间接成本。为分析COPD患者的社会成本，本研究对2004年至2013年韩国国家级健康调查数据和国家健康保险理赔数据库数据采用了数据挖掘和宏观成本核算方法。
2013年，1,419,914例COPD患者的社会总成本估计为4.399亿美元。COPD的直接医疗成本为2.143亿美元，其中住院成本9,630万美元、门诊成本7,640万美元、药品成本4,160万美元。直接非医疗成本估计为4,350万美元。2013年与COPD发病和死亡相关的间接总成本为1.822亿美元。
本研究表明，COPD对医疗成本有重大影响，尤其是直接医疗成本。因此，建议采取适当的长期干预措施以降低韩国COPD的经济负担。
